PITTSFORD, NY--(Marketwire - October 05, 2007) - Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced two transactions that uniquely position the Company to address the unmet needs for the multi-billion market opportunity for treating acute heart failure.
